Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
| Autor: | Li, Bob T, Meric-Bernstam, Funda, Bardia, Aditya, Naito, Yoichi, Siena, Salvatore, Aftimos, Philippe, Anderson, Ian, Curigliano, Giuseppe, de Miguel, Maria, Kalra, Maitri, Oh, Do-Youn, Park, Joon Oh, Postel-Vinay, Sophie, Rha, Sun Young, Satoh, Taroh, Spanggaard, Iben, Michelini, Flavia, Smith, Ann, Kalil Machado, Karime, Saura, Cristina, Machado, Karime Kalil |
|---|---|
| Zdroj: | In The Lancet Oncology June 2024 25(6):707-719 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|